Home NDC 81968-045 AUVELITY
Product NDC 81968-045
11-digit product format 819680045
Labeler code 81968
Product ID 81968-045_948d108e-f3a6-4e83-a4f2-ff8edf184e1b
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name dextromethorphan hydrobromide, bupropion hydrochloride
Dosage form TABLET, MULTILAYER, EXTENDED RELEASE
Route ORAL
Labeler Axsome Therapeutics, Inc.
Application NDA215430
Marketing category NDA
Marketing start 2022-08-18
Substance DEXTROMETHORPHAN HYDROBROMIDE; BUPROPION HYDROCHLORIDE
Active strength 45; 105 mg/1; mg/1
Pharmacologic classes Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N215430-001 AUVELITY BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE 105MG;45MG TABLET, EXTENDED RELEASE / ORAL RLD, RS 2022-08-18 N215430-002 AUVELITY BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE 105MG;30MG TABLET, EXTENDED RELEASE / ORAL RLD 2026-04-30
Orange Book patents# Current patent rows page 4 of 4 · 270 matching rows.
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 2 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N215430-001 I-913 2029-04-30 N215430-002 I-913 2029-04-30
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 N215430-001 AUVELITY 105MG;45MG TABLET, EXTENDED RELEASE / ORAL RLD, RS 2022-08-18 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N215430-002 AUVELITY 105MG;30MG TABLET, EXTENDED RELEASE / ORAL RLD 2026-04-30 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 N215430-001 AUVELITY 105MG;45MG TABLET, EXTENDED RELEASE / ORAL RLD, RS 2022-08-18 c2088c7a36db…2026-10-15 13:18:30 2026-09 N215430-002 AUVELITY 105MG;30MG TABLET, EXTENDED RELEASE / ORAL RLD 2026-04-30 c2088c7a36db…2026-09-14 22:38:34 2026-08 N215430-001 AUVELITY 105MG;45MG TABLET, EXTENDED RELEASE / ORAL RLD, RS 2022-08-18 84e616aacf4f…2026-09-14 22:38:34 2026-08 N215430-002 AUVELITY 105MG;30MG TABLET, EXTENDED RELEASE / ORAL RLD 2026-04-30 84e616aacf4f…2026-08-18 06:07:40 2026-07 N215430-001 AUVELITY 105MG;45MG TABLET, EXTENDED RELEASE / ORAL RLD, RS 2022-08-18 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N215430-002 AUVELITY 105MG;30MG TABLET, EXTENDED RELEASE / ORAL RLD 2026-04-30 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N215430-001 AUVELITY 105MG;45MG TABLET, EXTENDED RELEASE / ORAL RLD, RS 2022-08-18 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215430-001 AUVELITY 105MG;45MG TABLET, EXTENDED RELEASE / ORAL RLD, RS 2022-08-18 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N215430-001 AUVELITY 105MG;45MG TABLET, EXTENDED RELEASE / ORAL RLD, RS 2022-08-18 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N215430-001 AUVELITY 105MG;45MG TABLET, EXTENDED RELEASE / ORAL RLD, RS 2022-08-18 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N215430-001 AUVELITY 105MG;45MG TABLET, EXTENDED RELEASE / ORAL RLD, RS 2022-08-18 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N215430-001 AUVELITY 105MG;45MG TABLET, EXTENDED RELEASE / ORAL RLD, RS 2022-08-18 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N215430-001 AUVELITY 105MG;45MG TABLET, EXTENDED RELEASE / ORAL RLD, RS 2022-08-18 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N215430-001 AUVELITY 105MG;45MG TABLET, EXTENDED RELEASE / ORAL RLD, RS 2022-08-18 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N215430-001 AUVELITY 105MG;45MG TABLET, EXTENDED RELEASE / ORAL RLD, RS 2022-08-18 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N215430-001 AUVELITY 105MG;45MG TABLET, EXTENDED RELEASE / ORAL RLD, RS 2022-08-18 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N215430-001 AUVELITY 105MG;45MG TABLET, EXTENDED RELEASE / ORAL RLD, RS 2022-08-18 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N215430-001 AUVELITY 105MG;45MG TABLET, EXTENDED RELEASE / ORAL RLD, RS 2022-08-18 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N215430-001 AUVELITY 105MG;45MG TABLET, EXTENDED RELEASE / ORAL RLD, RS 2022-08-18 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N215430-001 AUVELITY 105MG;45MG TABLET, EXTENDED RELEASE / ORAL RLD, RS 2022-08-18 8072bd15b7f6…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N215430-001 AUVELITY 105MG;45MG TABLET, EXTENDED RELEASE / ORAL RLD, RS 2022-08-18 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N215430-001 AUVELITY 105MG;45MG TABLET, EXTENDED RELEASE / ORAL RLD, RS 2022-08-18 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N215430-001 AUVELITY 105MG;45MG TABLET, EXTENDED RELEASE / ORAL RLD, RS 2022-08-18 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N215430-001 AUVELITY 105MG;45MG TABLET, EXTENDED RELEASE / ORAL RLD, RS 2022-08-18 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N215430-001 AUVELITY 105MG;45MG TABLET, EXTENDED RELEASE / ORAL RLD, RS 2022-08-18 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N215430-001 AUVELITY 105MG;45MG TABLET, EXTENDED RELEASE / ORAL RLD, RS 2022-08-18 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N215430-001 AUVELITY 105MG;45MG TABLET, EXTENDED RELEASE / ORAL RLD, RS 2022-08-18 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N215430-001 AUVELITY 105MG;45MG TABLET, EXTENDED RELEASE / ORAL RLD, RS 2022-08-18 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N215430-001 AUVELITY 105MG;45MG TABLET, EXTENDED RELEASE / ORAL RLD, RS 2022-08-18 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N215430-001 AUVELITY 105MG;45MG TABLET, EXTENDED RELEASE / ORAL RLD, RS 2022-08-18 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N215430-001 AUVELITY 105MG;45MG TABLET, EXTENDED RELEASE / ORAL RLD, RS 2022-08-18 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N215430-001 AUVELITY 105MG;45MG TABLET, EXTENDED RELEASE / ORAL RLD, RS 2022-08-18 e64feba35796…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N215430-001 AUVELITY 105MG;45MG TABLET, EXTENDED RELEASE / ORAL RLD, RS 2022-08-18 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N215430-002 AUVELITY 105MG;30MG TABLET, EXTENDED RELEASE / ORAL RLD 2026-04-30 a50c72e98297…
Observed Orange Book patent history# Patent history page 1 of 105 · 4,193 observed states.
Observed Orange Book exclusivity history# Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base AUVELITY
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength DEXTROMETHORPHAN HYDROBROMIDE 45 mg/1 BUPROPION HYDROCHLORIDE 105 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 9D2RTI9KYH Internal UNII lookup ZG7E5POY8O Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 8 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2611260 Internal RxNorm lookup 2611266 Internal RxNorm lookup 2741701 Internal RxNorm lookup 2741703 Internal RxNorm lookup 2744512 Internal RxNorm lookup 2744513 Internal RxNorm lookup 2744514 Internal RxNorm lookup 2744515 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 81968-045-14 AUVELITY 14 in 1 BOTTLE TABLET, MULTILAYER, EXTENDED REL 14 14 81968-045-14 AUVELITY 1 in 1 CARTON TABLET, MULTILAYER, EXTENDED REL 1 14 81968-045-30 AUVELITY 30 in 1 BOTTLE TABLET, MULTILAYER, EXTENDED REL 30 14 81968-045-31 AUVELITY 30 in 1 BOTTLE TABLET, MULTILAYER, EXTENDED REL 30 14 81968-045-31 AUVELITY 1 in 1 CARTON TABLET, MULTILAYER, EXTENDED REL 1 14 81968-045-60 AUVELITY 60 in 1 BOTTLE TABLET, MULTILAYER, EXTENDED REL 60 14
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 81968-045 AUVELITY (DEXTROMETHORPHAN HYDROBROMIDE, BUPROPION HYDROCHLORIDE) TABLET, MULTILAYER, EXTENDED RELEASE [AXSOME THERAPEUTICS, INC.] 8 Current NDC, Legacy NDC, 6 package rows 20240920_dcefda7c-9a68-278e-e053-2995a90aec79.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join AUVELITY DEXTROMETHORPHAN HYDROBROMIDE, BUPROPION HYDROCHLORIDE Axsome Therapeutics, Inc. dcefda7c-9a68-278e-e053-2995a90aec79 2026-08-17 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (NDA): 215430 application number: NDA215430 ndc (product): 81968-045
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 81968-045-14 81968004514 1 BOTTLE in 1 CARTON (81968-045-14) / 14 TABLET, MULTILAYER, EXTENDED RELEASE in 1 BOTTLE 1 bottle 2024-09-18 Yes No Current 81968-045-30 81968004530 30 TABLET, MULTILAYER, EXTENDED RELEASE in 1 BOTTLE (81968-045-30) 2022-08-18 0000-00-00 No No Current 81968-045-31 81968004531 1 BOTTLE in 1 CARTON (81968-045-31) / 30 TABLET, MULTILAYER, EXTENDED RELEASE in 1 BOTTLE 1 bottle 2024-05-10 2027-03-28 Yes No Historical 81968-045-60 81968004560 60 TABLET, MULTILAYER, EXTENDED RELEASE in 1 BOTTLE (81968-045-60) 2024-06-28 No No Current